Smithfield Trust Co
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1019754
PITTSBURGH, PA
Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$224,609
-$3,431 QoQ
Shares Held
503
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Smithfield Trust Co holds $563,573 across 10 Biotechnology names. VRTX ranks #2 (39.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
332 | $256,516 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
503 | $224,609 | |
| 3 | INCY |
Incyte Corp
|
323 | $30,400 | |
| 4 | RPRX |
Royalty Pharma plc
|
603 | $28,925 | |
| 5 | CYTK |
Cytokinetics Inc
|
155 | $10,216 | |
| 6 | TECH |
BIO-TECHNE Corp
|
148 | $7,734 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
606 | $2,393 | |
| 8 | ARGX |
Argenx SE
|
2 | $1,460 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $224,609 | 503 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $228,040 | 503 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $196,994 | 503 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $223,935 | 503 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $243,864 | 503 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $264,976 | 658 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $306,022 | 658 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $308,417 | 658 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $275,050 | 658 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $282,381 | 694 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $285,145 | 820 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $288,565 | 820 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $255,205 | 810 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $229,291 | 794 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $225,550 | 779 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $145,403 | 516 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $134,660 | 516 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $117,266 | 534 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $96,861 | 534 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $112,710 | 559 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $120,122 | 559 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $132,113 | 559 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $262,595 | 965 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $298,437 | 1,028 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $121,354 | 510 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||